|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,000.00 GBX | -0.46% |
|
+0.54% | +24.15% |
| 12-12 | Ice-cream spin-off turns up heat on Unilever to deliver on growth, margins | RE |
| 12-12 | AlphaValue/Baader Europe Ups Reckitt Benckiser Price Target Amid Sales Beat, Margin Improvement | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.2 | 5.86 | 7.54 | 7.42 | 8.22 | |||||
Return on Total Capital | 9.51 | 9.27 | 11.77 | 11.59 | 13.17 | |||||
Return On Equity % | 12.42 | -0.63 | 27.82 | 18.36 | 18.86 | |||||
Return on Common Equity | 12.31 | -0.76 | 27.75 | 18.27 | 18.88 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 60.28 | 58.11 | 57.85 | 59.97 | 60.66 | |||||
SG&A Margin | 35.76 | 35.14 | 32.41 | 34.96 | 35.24 | |||||
EBITDA Margin % | 24.87 | 22.84 | 25.23 | 24.74 | 26.44 | |||||
EBITA Margin % | 23.1 | 21.13 | 23.53 | 22.91 | 24.55 | |||||
EBIT Margin % | 22.48 | 20.63 | 23.25 | 22.72 | 24.34 | |||||
Income From Continuing Operations Margin % | 8.24 | -0.39 | 16.3 | 11.28 | 10.11 | |||||
Net Income Margin % | 8.48 | -0.24 | 16.12 | 11.25 | 10.06 | |||||
Net Avail. For Common Margin % | 8.13 | -0.48 | 16.17 | 11.19 | 10.09 | |||||
Normalized Net Income Margin | 12.65 | 15.37 | 13.32 | 12.93 | 13.7 | |||||
Levered Free Cash Flow Margin | 17.89 | 19.17 | 20.11 | 15.51 | 14.86 | |||||
Unlevered Free Cash Flow Margin | 19.12 | 20.32 | 21.12 | 16.78 | 16.6 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.44 | 0.45 | 0.52 | 0.52 | 0.54 | |||||
Fixed Assets Turnover | 6.4 | 6 | 6.22 | 6 | 5.92 | |||||
Receivables Turnover (Average Receivables) | 8.55 | 8.52 | 8.83 | 8.52 | 8.2 | |||||
Inventory Turnover (Average Inventory) | 3.83 | 3.63 | 3.71 | 3.38 | 3.53 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.77 | 0.62 | 0.63 | 0.64 | 0.58 | |||||
Quick Ratio | 0.52 | 0.4 | 0.4 | 0.41 | 0.36 | |||||
Operating Cash Flow to Current Liabilities | 0.51 | 0.21 | 0.29 | 0.32 | 0.34 | |||||
Days Sales Outstanding (Average Receivables) | 42.8 | 42.86 | 41.35 | 42.84 | 44.62 | |||||
Days Outstanding Inventory (Average Inventory) | 95.68 | 100.43 | 98.38 | 108.06 | 103.55 | |||||
Average Days Payable Outstanding | 124.02 | 142.43 | 125.19 | 147.06 | 149.71 | |||||
Cash Conversion Cycle (Average Days) | 14.47 | 0.86 | 14.54 | 3.84 | -1.54 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 115.26 | 129.26 | 96.3 | 103.01 | 131.41 | |||||
Total Debt / Total Capital | 53.55 | 56.38 | 49.06 | 50.74 | 56.79 | |||||
LT Debt/Equity | 106.93 | 95.92 | 78.15 | 83.19 | 110.24 | |||||
Long-Term Debt / Total Capital | 49.68 | 41.84 | 39.81 | 40.98 | 47.64 | |||||
Total Liabilities / Total Assets | 70.73 | 72.34 | 67.01 | 68.79 | 73.44 | |||||
EBIT / Interest Expense | 11.39 | 11.19 | 14.42 | 11.25 | 8.78 | |||||
EBITDA / Interest Expense | 12.9 | 12.68 | 16.01 | 12.58 | 9.75 | |||||
(EBITDA - Capex) / Interest Expense | 11.47 | 11.15 | 14.45 | 11.4 | 8.81 | |||||
Total Debt / EBITDA | 2.97 | 3.11 | 2.45 | 2.35 | 2.31 | |||||
Net Debt / EBITDA | 2.5 | 2.71 | 2.14 | 1.98 | 2.08 | |||||
Total Debt / (EBITDA - Capex) | 3.33 | 3.54 | 2.71 | 2.59 | 2.55 | |||||
Net Debt / (EBITDA - Capex) | 2.81 | 3.08 | 2.37 | 2.18 | 2.3 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.93 | -5.42 | 9.21 | 1.07 | -3 | |||||
Gross Profit, 1 Yr. Growth % | 8.45 | -8.83 | 8.73 | 4.77 | -1.88 | |||||
EBITDA, 1 Yr. Growth % | -2.25 | -13.29 | 20.68 | -0.9 | 2.63 | |||||
EBITA, 1 Yr. Growth % | -2.71 | -13.65 | 21.64 | -1.59 | 2.81 | |||||
EBIT, 1 Yr. Growth % | -0.44 | -13.33 | 23.11 | -1.25 | 2.8 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -141.59 | -104.51 | -4.63K | -30.05 | -13.11 | |||||
Net Income, 1 Yr. Growth % | -132.23 | -102.7 | -7.38K | -29.48 | -13.21 | |||||
Normalized Net Income, 1 Yr. Growth % | -5.21 | 14.9 | -5.34 | -1.88 | -2.57 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -140.53 | -105.54 | -3.79K | -30.18 | -10.38 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.27 | -0.39 | 11.15 | -1.1 | 2.64 | |||||
Inventory, 1 Yr. Growth % | 21.16 | -8.35 | 25.09 | -10.3 | -7.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.35 | -2.46 | 13.54 | -2.99 | -0.58 | |||||
Total Assets, 1 Yr. Growth % | -2.64 | -13.89 | 6.67 | -5.59 | -6.77 | |||||
Tangible Book Value, 1 Yr. Growth % | -6.94 | -17.28 | -6.18 | -5.76 | 7.16 | |||||
Common Equity, 1 Yr. Growth % | -2.65 | -18.83 | 27.63 | -10.54 | -20.7 | |||||
Cash From Operations, 1 Yr. Growth % | 149.33 | -51.76 | 41.25 | 9.97 | 1.74 | |||||
Capital Expenditures, 1 Yr. Growth % | 28.76 | -5.33 | -2.95 | -3.87 | 6.32 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 43.98 | 1.22 | 14.6 | -22.05 | -7.62 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 37.54 | 0.39 | 13.51 | -19.73 | -4.9 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 4.98 | 5.02 | 4.99 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.4 | 1.5 | 1.63 | 5.06 | -0.99 | |||||
Gross Profit, 2 Yr. CAGR % | 5.11 | -0.57 | -0.44 | 6.73 | 1.39 | |||||
EBITDA, 2 Yr. CAGR % | -2.65 | -7.87 | 2.3 | 9.36 | 1.35 | |||||
EBITA, 2 Yr. CAGR % | -3.2 | -8.27 | 2.49 | 9.41 | 1.13 | |||||
EBIT, 2 Yr. CAGR % | -3.35 | -7.04 | 3.29 | 10.26 | 1.3 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -27.34 | -86.3 | 42.95 | 462.96 | -22.04 | |||||
Net Income, 2 Yr. CAGR % | -25.85 | -90.68 | 40.1 | 616.55 | -21.77 | |||||
Normalized Net Income, 2 Yr. CAGR % | -2.82 | 4.36 | 4.29 | -3.63 | 0.42 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -27.75 | -85.01 | 42.99 | 407.58 | -20.9 | |||||
Accounts Receivable, 2 Yr. CAGR % | -7.89 | -4.93 | 5.23 | 4.85 | 0.75 | |||||
Inventory, 2 Yr. CAGR % | 11.7 | 5.37 | 7.07 | 5.92 | -8.83 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.63 | 0.88 | 5.24 | 4.95 | -1.8 | |||||
Total Assets, 2 Yr. CAGR % | -9.2 | -8.43 | -4.16 | 0.35 | -6.18 | |||||
Tangible Book Value, 2 Yr. CAGR % | -5.59 | -12.26 | -11.9 | -5.97 | 0.49 | |||||
Common Equity, 2 Yr. CAGR % | -21.32 | -11.1 | 1.78 | 6.85 | -15.77 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.06 | 9.67 | -17.46 | 24.63 | 5.78 | |||||
Capital Expenditures, 2 Yr. CAGR % | 7.33 | 10.41 | -4.15 | -3.41 | 1.1 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 16.85 | 20.8 | 7.7 | -5.49 | -14.88 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 13.65 | 17.57 | 6.75 | -4.54 | -12.23 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.14 | 0 | 2.46 | 5 | 5 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.92 | 1.66 | 4.01 | 1.44 | 2.3 | |||||
Gross Profit, 3 Yr. CAGR % | 6.5 | 0.24 | 2.44 | 1.27 | 3.78 | |||||
EBITDA, 3 Yr. CAGR % | 1.2 | -6.29 | 0.81 | 1.22 | 7.42 | |||||
EBITA, 3 Yr. CAGR % | 0.76 | -6.77 | 0.78 | 1.11 | 7.55 | |||||
EBIT, 3 Yr. CAGR % | 0.34 | -6.75 | 2.09 | 1.76 | 8.1 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -30.22 | -71.23 | -5.28 | 12.64 | 201.98 | |||||
Net Income, 3 Yr. CAGR % | -42.28 | -75.44 | -14.15 | 11.45 | 254.53 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.69 | 2.76 | 1.02 | 2.19 | -1.54 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -30.51 | -69.31 | -6.07 | 12.6 | 184.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.32 | -5.45 | 0.16 | 3.07 | 4.11 | |||||
Inventory, 3 Yr. CAGR % | 9.85 | 4.57 | 11.57 | 0.93 | 1.31 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.38 | 0.25 | 4.94 | 2.42 | 3.07 | |||||
Total Assets, 3 Yr. CAGR % | -5.44 | -10.79 | -3.66 | -4.64 | -2.08 | |||||
Tangible Book Value, 3 Yr. CAGR % | -4.57 | -9.66 | -10.28 | -9.9 | -1.78 | |||||
Common Equity, 3 Yr. CAGR % | -12.34 | -20.5 | 0.28 | -2.5 | -3.26 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.2 | -12.39 | 19.32 | -9.17 | 16.48 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.27 | 2.93 | 5.76 | -4.05 | -0.27 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.47 | 11.43 | 18.69 | -3.3 | -6.01 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 0.71 | 9.09 | 16.2 | -2.93 | -4.37 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2.05 | 0.76 | 1.63 | 3.31 | 5 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.54 | 6.9 | 4.77 | 3.01 | 1.98 | |||||
Gross Profit, 5 Yr. CAGR % | 9.96 | 5.8 | 3.67 | 2.79 | 2.02 | |||||
EBITDA, 5 Yr. CAGR % | 6.65 | 1.74 | 1.66 | -0.32 | 1.02 | |||||
EBITA, 5 Yr. CAGR % | 6.28 | 0.74 | 1.48 | -0.6 | 0.92 | |||||
EBIT, 5 Yr. CAGR % | 5.86 | 0.75 | 1.54 | -0.29 | 1.77 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -7.95 | -50.4 | -7.04 | -5.48 | -12.37 | |||||
Net Income, 5 Yr. CAGR % | -7.4 | -55.49 | -17.7 | -5.32 | -17.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.91 | 4.48 | 1.27 | 0.16 | 0.78 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -7.94 | -48.43 | -7.26 | -5.72 | -12.31 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.99 | 1.27 | 0.01 | -1.46 | 0.39 | |||||
Inventory, 5 Yr. CAGR % | 18.51 | 13.64 | 8.73 | 5.11 | 2.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 25.06 | 19.93 | 7.11 | 2.1 | 2.19 | |||||
Total Assets, 5 Yr. CAGR % | 15.43 | 8.38 | -4.93 | -6.49 | -4.67 | |||||
Tangible Book Value, 5 Yr. CAGR % | 25.85 | 17.91 | -7.58 | -8.2 | -6.12 | |||||
Common Equity, 5 Yr. CAGR % | 5.71 | -2.55 | -6.94 | -10.52 | -6.48 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.55 | -6.87 | -0.77 | 0.87 | 13.71 | |||||
Capital Expenditures, 5 Yr. CAGR % | 20.67 | 16.21 | 4.83 | 0.35 | 3.87 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.32 | 10.4 | 3.33 | 4.33 | 3.91 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.43 | 11.24 | 3.11 | 3.42 | 3.87 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.67 | 2.65 | 2.21 | 2.43 | 2.97 |
- Stock Market
- Equities
- RB. Stock
- Financials Reckitt Benckiser Group plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















